Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biodetection

    DHS Award for Biothreat Antibody Development

    By Global Biodefense StaffJuly 14, 2014
    Share
    Facebook LinkedIn Reddit Email

    The DHS Directorate of Science and Technology, Chemical and Biological Defense Division has awarded a sole source contract to Silver Lake Research Corporation (SLRC) for continued development of threat agent specific monoclonal antibodies supporting development of rapid detection assays.

    SLRC has produced a group of highly specific monoclonal antibodies for use in DHS and FEDGOV assays. DHS requires that SLRC continue and complete the work for the research, development and generation of hyper-specific monoclonal antibodies specific for bacterial and viral biothreat agents.

    The overall objective is to develop and deploy highly specific and sensitive rapid first responder, clinical diagnostic, and biothreat detection assays capable of fulfilling the needs of multiple agencies and departments to support the national biodefense and preparedness mission. This requirement was originally awarded to Silver Lake Research Corporation (SLRC) on June 4, 2012 under DHS Long Range Broad Agency Announcement 11-03, with several continuation contracts since that time.

    “Using an innovative and proprietary EAP Immunization methods, SLRC has overcome the technical problems associated with the work that has been performed thus far under the previous and current DHS contracts to overcome the probable “non-immunogenicity” of selected sequences, and ensure that the antibodies are designed to bind to the selected sequence in the context of the intact native protein,” states the announcement.

    Previously completed results from SLRC showed that of the four Bacillus anthracis antigenic marker peptides used, all four produced specific MAbs which are now being characterized by DHS, U.S. Center for Disease Control (CDC), and other Federal Research Laboratories.

    “This accomplishment marks the first successful attempt to employ cytokine mediated artificial host responses, coupled with bioinformatics driven recombinant antigens as a rational approach to generating highly specific antibodies to support the development of rapid detection assays for the national biodefense and preparedness mission,” states the announcement.

    Anthrax Awards Bioinformatics Chemical Detection DHS
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleRadiation Detector Designed For Broad Public Use
    Next Article Transcript of CDC Press Conference on Biosafety Incidents

    Related Stories

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    Oct 17
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Dispensing and Administration of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.